Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CDXC > SEC Filings for CDXC > Form 8-K on 18-Oct-2013All Recent SEC Filings

Show all filings for CHROMADEX CORP.

Form 8-K for CHROMADEX CORP.


18-Oct-2013

Unregistered Sale of Equity Securities, Financial Statements and Exhibits


Item 3.02 Unregistered Sales of Equity Securities

On October 17, 2013, ChromaDex Corporation (the "Company") sold an aggregate of 2,941,176 shares of the Company's common stock, $0.001 par value per share (the "Common Stock") with gross proceeds to the Company of $2,500,000 to a certain strategic accredited investor pursuant to a subscription agreement. The proceeds from this offering will be used to further develop the Company's novel nutritional ingredients. Each share of common stock was sold for a purchase price of $0.85 per share.

On October 18, 2013, the Company sold an aggregate of 588,235 shares of the Company's Common Stock, with gross proceeds to the Company of $500,000 to a certain strategic accredited investor pursuant to a subscription agreement. The proceeds from this offering will be used for general working capital purposes. Each share of Common Stock was sold for a purchase price of $0.85 per share on the same terms of the investment made by the strategic accredited investor on October 17, 2013. A fee of $20,000 was paid to a placement agent in connection with this $500,000 investment.

The shares of Common Stock were issued in reliance upon an exemption from registration provided by Rule 506 of Regulation D of the Securities Act of 1933, as amended (the "Securities Act") since no general solicitation or advertising was conducted by us in connection with the offering of any of the shares, all shares purchased in the offering were restricted in accordance with Rule 144 of the Securities Act and each of these shareholders were either accredited as defined in Rule 501 (a) of Regulation D promulgated under the Securities Act or sophisticated as defined in Rule 506(b)(2)(ii) of Regulation D promulgated under the Securities Act.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

10.1 Form of Subscription Agreement


  Add CDXC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CDXC - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.